Morgan Stanley Upgrades ResMed (RMD) to Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015
July 30, 2015 4:06 PM EDTSAN DIEGO, July 30, 2015 /PRNewswire/ --Â ResMed Inc. (NYSE: RMD) today announced results for its quarter ended June 30, 2015. Â Revenue for the quarter was $453.1 million, a 9 percent increase compared with the quarter ended June 30, 2014 (a 17 percent increase on a constant currency basis). Â Net income was $87.5 million, consistent with the quarter ended June 30, 2014. Â Diluted earnings per share for the quarter were $0.61, consistent with the quarter ended June 30, 2014.Â
The results for the quarter ended June 30, 2015 were impacted by two non-recurring items: first, expenses of $5.0 million ($3.5 million, net of tax) associated with the field... More
